Prostate cancer associated with CYP17 genotype

Pharmacogenetics

Volumn 9, Issue 5, 1999, Pages 635-639

  Wadelius, Mia ^a   Andersson, Swen Olof ^b   Johansson, Jan Erik ^b   Wadelius, Claes ^a   Rane, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

CYP17; Cytochrome P450(17 ); Prostate cancer; Steroid 17 hydroxylase

Indexed keywords

ANDROGEN; CYTOCHROME P450 ISOENZYME; CYTOCHROME P450C17ALPHA; DNA FRAGMENT; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASE PAIRING; BREAST CANCER; CANCER GENETICS; CASE CONTROL STUDY; CATALYSIS; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY HISTORY; GENE CONTROL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; SWEDEN; TESTOSTERONE SYNTHESIS;

EID: 0032742707     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199910000-00010     Document Type: Article

References (30)

1. Adams JB. Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat 1998; 51:183-188.
2. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wöhr G, et al. Predisposing gene for early onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998; 62:1416-1424.
3. Brown TR. Provocative aspects of androgen genetics. Prostate 1996; 6 (Suppl.):9-12.
4. Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3:1873-1876.
5. Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1990; 16:187-197.
6. Carter BS, Bova S, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150:797-802.
7. Conney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, et al. Prostate cancer susceptibility locus on chromosome 1q. A confirmatory study. J Natl Cancer Inst 1997; 89:955-959.
8. Dunning AM, Healey CS, Pharoah PD, Poster NA, Lipscombe JM, Redman KL, et al. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer 1998; 77:2045-2047.
9. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. Polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997; 57:1063-1065.
10. Feigelson HS, Shames LS, Pike M, Coetzee GA, Stanczyk FZ, Henderson BE. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesteron concentrations. Cancer Res 1998; 58:585-587.
11. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci E, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994; 86:281-286.
12. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85:1571-1579.
13. Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 1998; 7:945-949.
14. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89:166-170.
15. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7:83-94.
16. Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, et al. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993; 2:1799-1802.
17. McConnell JD. Prostatic growth: new insights into hormonal regulation. Br J Urol 1995; 76 (Suppl. 1):5-10.
18. Makridakis N, Reichardt JKV, Pike MC, Stanczyk FZ, Yu MC, Kolonel LN, et al. Genetic control of human androgen metabolism by the CYP17 and SRDA2 genes [abstract]. Am Soc Hum Genet 1997; 1497.
19. Picado-Leonard J, Miller WL. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 1987; 6:439-448.
20. Ross RK. Epidemiology of prostate cancer and bladder cancer: an overview. Cancer Treat Res 1996; 88:1-11.
21. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994; 86:252-254.
22. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986; 76:45-48.
23. Ross RK, Coetzee GA, Reichardt JKV, Skinner E, Henderson BE. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer 1995; 75:1778-1782.
24. Ross RK, Pike MC, Coetzee GA, Reichardt JKV, Yu MC, Feigelson HS, et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 1998; 58:4497-4504.
25. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274:1371-1373.
26. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57:1194-1198.
27. Techatraisak K, Conway GS, Rumsby G. Frequency of a polymorphism in the regulatory region of the 17-α-hydroxylase-17,20- lyase (CYP17) gene in the hyperandrogenic states. Clin Endocrinol 1997; 46:131-134.
28. Weston A, Pan CF, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS. CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7:941-944.
29. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusshern D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genet 1998; 20:175-179.
30. Yanase T. 17α-Hydroxylase/17,20-lyase defects. J Steroid Biochem Mol Biol 1995; 53:153-157.